AORT
ARTIVION, INC.
NYSE · Healthcare · Medical - Devices · US
$22.28
+2.30%Year over year
Reported trailing growth
- Revenue
- +16.4%
- EBITDA
- +28.3%
- EBIT
- +7.1%
- EPS
- +86.0%
- Free cash flow
- —
- Operating cash flow
- +103.3%
Forward estimates
Based on analyst estimates
- Revenue
- +12.5%
- EBITDA
- +33.4%
- EPS
- +671.2%
Three-year CAGR
- Revenue
- +12.0%
- EBITDA
- +35.4%
- EBIT
- +62.8%
- Net income
- +173.1%
- EPS
- +168.8%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026